Neuberger Berman Group LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 205 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,249,484
+32.6%
39,132
+27.1%
0.00%0.0%
Q1 2023$942,514
-18.8%
30,781
+3.7%
0.00%0.0%
Q4 2022$1,161,254
+9.0%
29,692
+32.9%
0.00%0.0%
Q3 2022$1,065,000
+22.7%
22,349
-0.3%
0.00%0.0%
Q2 2022$868,000
-33.1%
22,421
-0.9%
0.00%0.0%
Q1 2022$1,297,000
-37.3%
22,629
-14.7%
0.00%
-50.0%
Q4 2021$2,069,000
-8.4%
26,529
-0.0%
0.00%0.0%
Q3 2021$2,258,000
-32.0%
26,533
+2.8%
0.00%
-33.3%
Q2 2021$3,319,00025,8080.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders